logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kazuo Kasahara

nippon medical school
H指数:40
被引数:9,552

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Case of Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings

1例接受帕博利珠单抗联合表柔比星和环磷酰胺治疗后出现以过敏性肺炎样表现的高敏性间质性肺病：首例病理学发现报告

INTERNAL MEDICINE
IF1.1
2025-10-011
OA
Kaburaki, Shota; Tanaka, Toru; Kamio, Koichiro; Tanaka, Yosuke; Kasahara, Kazuo; Terasaki, Yasuhiro; Seike, Masahiro
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic EGFR-mutated NSCLC

RELAY研究：雷莫芦单抗联合厄洛替尼在老年日本患者中针对转移性EGFR突变非小细胞肺癌的安全性与有效性

FUTURE ONCOLOGY
IF2.6
2025-09-010
PRE
Nishino, Kazumi; Seto, Takashi; Nishio, Makoto; Nishio, Kazuto; Kasahara, Kazuo; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Enatsu, Sotaro; Matsui, Tomoko; Varughese, Sunoj Chacko; Visseren-Grul, Carla; Nakagawa, Kazuhiko
Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset

拉姆昔利单抗联合厄洛替尼对比安慰剂联合厄洛替尼，用于未治EGFR突变型转移性非小细胞肺癌患者的最终生存结局：RELAY日本亚组

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-02-010
OAAI
Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Nishio, Kazuto; Kasahara, Kazuo; Nishino, Kazumi; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Sakai, Kazuko; Enatsu, Sotaro; Frimodt-Moller, Bente; Matsui, Tomoko; Varughese, Sunoj Chacko; Carlsen, Michelle; Visseren-Grul, Carla; Nakagawa, Kazuhiko
Retrospective study on the tolerability of anti-PD-L1 antibody plus platinum-etoposide for elderly patients with extensive- stage small-cell lung cancer based on body mass index

基于体质量指数的回顾性研究：PD-L1抗体联合铂类-依托泊苷在广泛期小细胞肺癌老年患者中的耐受性

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Terashima, Y.; Takeuchi, S.; Inoue, T.; Miyadera, K.; Tozuka, T.; Kitagawa, S.; Fukuizumi, A.; Hisakane, K.; Onda, N.; Miyanaga, A.; Kasahara, K.; Seike, M.
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
LANCET RESPIRATORY MEDICINE
IF32.8
2024-11-011
PRE
Shiraishi, Yoshimasa; Nomura, Shogo; Sugawara, Shunichi; Horinouchi, Hidehito; Yoneshima, Yasuto; Hayashi, Hidetoshi; Azuma, Koichi; Hara, Satoshi; Niho, Seiji; Morita, Ryo; Yamaguchi, Masafumi; Yokoyama, Toshihide; Yoh, Kiyotaka; Kurata, Takayasu; Okamoto, Hiroaki; Okamoto, Masaki; Kijima, Takashi; Kasahara, Kazuo; Fujiwara, Yutaka; Murakami, Shuji; Kanda, Shintaro; Akamatsu, Hiroaki; Takemoto, Shinnosuke; Kaneda, Hiroyasu; Kozuki, Toshiyuki; Ando, Masahiko; Sekino, Yuta; Fukuda, Haruhiko; Ohe, Yuichiro; Okamoto, Isamu
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer
TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2024-11-010
OAAI
Terada, Nanao; Koba, Hayato; Nanjo, Shigeki; Kimura, Hideharu; Nishiyama, Akihiro; Yoneda, Taro; Takeda, Takayuki; Shirasaki, Hiroki; Nishi, Koichi; Sone, Takashi; Yamada, Tadaaki; Takayama, Koichi; Shibata, Kazuhiko; Matsuoka, Hiroki; Kita, Toshiyuki; Nagata, Kazuhiro; Tambo, Yuichi; Ohkura, Noriyuki; Hara, Johsuke; Kasahara, Kazuo; Kohsaka, Shinji; Mano, Hiroyuki; Yano, Seiji
IgA vasculitis induced by carboplatin plus nab-paclitaxel plus pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report
FRONTIERS IN IMMUNOLOGY
IF5.9
2024-08-140
OAAI
Terashima, Yuto; Matsumoto, Masaru; Ozaki, Saeko; Nakagawa, Michiko; Nakagome, Shun; Terasaki, Yasuhiro; Iida, Hiroki; Mitsugi, Ryotaro; Kuramochi, Eri; Okada, Naoko; Inoue, Tomoyasu; Matsuki, Satoru; Kitagawa, Shingo; Fukuizumi, Aya; Onda, Naomi; Takeuchi, Susumu; Miyanaga, Akihiko; Kasahara, Kazuo; Seike, Masahiro
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC

铂类双重化疗联合免疫检查点抑制剂治疗晚期非鳞状NSCLC患者TTF-1表达弥漫性阳性的预测作用

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-11-011
OA
Terashima, Yuto; Matsumoto, Masaru; Iida, Hiroki; Takashima, Sae; Fukuizumi, Aya; Takeuchi, Susumu; Miyanaga, Akihiko; Terasaki, Yasuhiro; Kasahara, Kazuo; Seike, Masahiro
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings

在现实环境中使用免疫检查点抑制剂单药治疗的非小细胞肺癌患者的长期生存

CLINICAL LUNG CANCER
IF3.3
2022-09-0115
PRE
Yoneda, Taro; Sone, Takashi; Koba, Hayato; Shibata, Kazuhiko; Suzuki, Junya; Tani, Mayuko; Nishitsuji, Masaru; Nishi, Koichi; Kobayashi, Takafumi; Shirasaki, Hiroki; Araya, Tomoyuki; Kita, Toshiyuki; Kase, Kazumasa; Yamamura, Kenta; Terada, Nanao; Nishikawa, Shingo; Tambo, Yuichi; Kimura, Hideharu; Kasahara, Kazuo
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors

一项开放标签，交叉研究，以比较不同的配方并评估食物对晚期实体瘤患者pimitespib药代动力学的影响

INVESTIGATIONAL NEW DRUGS
IF2.7
2022-08-063
OAAI
Komatsu, Yoshito; Shimokawa, Tsuneo; Akiyoshi, Kohei; Karayama, Masato; Shimomura, Akihiko; Kawamoto, Yasuyuki; Yuki, Satoshi; Tambo, Yuichi; Kasahara, Kazuo

研究方向

暂未获取到该数据
H
Hideharu Kimura
H 指数:29论文数:187被引数:3,502
T
Takashi Sone
H 指数:22论文数:147被引数:1,785
N
Noriyuki Ohkura
H 指数:21论文数:132被引数:1,372
H
Hayato Koba
H 指数:11论文数:91被引数:776
S
Satoshi Watanabe
H 指数:36论文数:265被引数:6,289
T
Taro Yoneda
H 指数:10论文数:58被引数:260
Y
Yuichi Tambo
H 指数:15论文数:96被引数:1,134
J
Johsuke Hara
H 指数:16论文数:92被引数:877
M
Masaki Fujimura
H 指数:43论文数:619被引数:7,738
K
Kazuhiko Shibata
H 指数:16论文数:112被引数:5,598